eXoZymes, Inc.

NASDAQ:EXOZ

Biotechnology

Healthcare
$5.54 +16.75%

+$1.06 today

Market cap
$51.42M
Beta
2.66
P/E (TTM)
-6.5
EPS (TTM)
-$1.14
52W Low $6.33High $18.40

Volume 0.01M

Average 0.01M

EXOZ Other Non-current Assets

Long-term assets not reported separately.

eXoZymes, Inc.NASDAQ: EXOZ

Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Other non-current assets remains negative

Q1 FY2026 other non-current assets was $105.21K, compared with $0 a year earlier.

Context

  • Other non-current assets amounted to 2.6% of total assets at the end of Q1 FY2026, up 2.6 pp from a year earlier.
  • Other non-current assets increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$105.21K+159.5% QoQ
Last fiscal yearDec 2025
-$176.77K— YoY
Year agoMar 2025
$0— since
Other Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-current Assets history

USD · from the balance sheet

Latest · FY2025
(176.77K) USD
Year-over-year change
—

Other Non-current Assets vs competitors

How EXOZ compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
  • Other non-current assets amounts to 2.6% of total assets for EXOZ, versus a peer median of 0.0%.
EXOZ Competitors
Other Non-current Assets for EXOZ and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TILInstil Bio, Inc.Mar 2026$11.95M USD+18.7%+50.9%6.0%
EXOZeXoZymes, Inc.Mar 2026$105.21K USD——2.6%
SRZNSurrozen, Inc.Mar 2026$34K USD-66.3%-66.6%0.0%
GLSIGreenwich LifeSciences, Inc.Mar 2026$0 USD——0.0%
CGTXCognition Therapeutics, Inc.Mar 2026$0 USD——0.0%
ONCYOncolytics Biotech Inc.Mar 2026CA$0 CAD——0.0%
TLSATiziana Life Sciences LtdDec 2025$0 USD——0.0%
Peer median (excluding EXOZ) —-23.8%-7.8%0.0%

Competitors are the stored peer set for EXOZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents547.81K558.57K66.53K9.72M3.04M
Short-term Investments00000
Net Receivables468.35K809.53K882.32K737.28K517.36K
Inventory00000
Other Current Assets30.19K101.14K264.76K363.79K382.89K
Total Current Assets1.05M1.47M1.21M10.82M3.94M
Property, Plant & Equipment (Net)1.3M1.22M2.34M2.21M2.21M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0000(176.77K)
Total Non-current Assets1.3M1.22M2.34M2.21M2.03M
Total Assets2.35M2.69M3.56M13.03M5.97M
Account Payables267.3K385.8K702.91K924.25K1.24M
Short-term Debt00000
Tax Payables063.56K42.27K00
Deferred Revenue00000
Other Current Liabilities001M00
Total Current Liabilities400.78K634.36K2.42M1.33M1.57M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)161.11K215K140.7K00
Other Non-current Liabilities000123.58K90.37K
Total Non-current Liabilities748.25K678.77K1.53M1.28M1.01M
Total Liabilities1.15M1.31M3.94M2.61M2.57M
Common Stock126688
Retained Earnings(2.65M)(4.05M)(6.08M)(11.95M)(21.1M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.2M1.37M(384.32K)10.42M3.4M
Total Debt720.63K608.77K1.61M1.39M1.24M
Net Debt172.82K50.2K1.55M(8.33M)(1.8M)

eXoZymes, Inc.

NASDAQ:EXOZ

Intrinsic Alpha fair value

Locked

Current Price

$5.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.